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http://dx.doi.org/10.1016/j.pedneo.2Status epilepticus in childhood is more common, with a different range of causes and a lower
risk of death, than convulsive status epilepticus in adults. Acute central nervous system infec-
tions appear to be markers for morbidity and mortality. Nevertheless, central nervous infec-
tion is usually presumed in these conditions. Many aspects of the pathogenesis of acute
encephalitis and acute febrile encephalopathy with status epilepticus have been clarified in
the past decade. The pathogenesis is divided into direct pathogens invasion or immune-
mediated mechanisms. Over the past few decades, the number of antineuronal antibodies
to ion channels, receptors, and other synaptic proteins described in association with central
nervous system disorders has increased dramatically, especially their role in pediatric enceph-
alitis and status epilepticus. These antineuronal antibodies are divided according to the loca-
tion of their respective antigens: (1) intracellular antigens, including glutamic acid
decarboxylase and classical onconeural antigens such as Hu (antineuronal nuclear antibody
1, ANNA1), Ma2, Yo (Purkinje cell autoantibody, PCA1), Ri (antineuronal nuclear antibody 2,
ANNA2), CV2/CRMP5, and amphiphysin; and (2) cell membrane ion channels or surface anti-
gens including voltage-gated potassium channel receptor, N-methyl-D-aspartate receptor, a-
amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor, g-aminobutyric acid(B) recep-
tor, leucine-rich glioma-inactivated protein 1, and contactin-associated protein-like 2. Identi-
fying the mechanism of the disease may have important therapeutic implications.
Copyright ª 2013, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. All rights
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162 K.-L. Lin, H.-S. Wang1. Introduction refractory partial seizures persisting from the onset of en-The estimated incidence of status epilepticus in childhood
ranges from 10 to 38/100,000/year. It is higher than 4-6/
100,000/year, as reported in the epidemiological studies of
status epilepticus in adults.1e3 There is evidence that eti-
ology is an important determinant of the outcome of pa-
tients with status epilepticus, and therefore it is important
to identify and classify the causes.4e6 Pediatric status
epilepticus is more common, with a different range of
causes, and a lower risk of death than that in adults. Acute
central nervous system infections appeared to be markers
for morbidity and mortality.7 Nevertheless, central nervous
system infection is usually presumed in these conditions.8
The pathogenesis is divided into direct pathogens infec-
tion or immune-mediated inflammation mechanisms.9,10
When faced with children presenting with febrile status
epilepticus, infectious pathogens are rarely found in the
cerebrospinal fluid (CSF). However, a group of patients
show evidence of infectious pathogens from the antibodies
in serum and virus isolation from throat or rectum. Never-
theless, the etiology of all of these children with febrile
status epilepticus was considered as presumed encephali-
tis.8,11,12 The immune-mediated mechanism and related
brain inflammation process may play important roles.2. Similar conditions of children with
antineuronal antibodies related
encephalopathy and febrile status epilepticus
Children with acute encephalopathy and febrile status
epilepticus usually have a catastrophic course and are
resistant to multiple antiepileptic drugs. The mechanism of
these patients remains unknown, although the clinical
features and experimental models point to a likely vicious
cycle involving inflammation and seizure activity.13e15
A similar pattern of clinical characteristics which sug-
gests suspected but unproven encephalitis with febrile
status epilepticus has been reported under various clinical
medical names, including severe refractory status epi-
lepticus in children,12 idiopathic catastrophic epileptic
encephalopathy presenting with acute-onset intractable
status epilepticus,16 and severe refractory status epi-
lepticus due to presumed encephalitis.11 Moreover, several
abbreviation medical terms in different areas and study
groups described these similar conditions in the literature,
which all represent unique characteristics as part of this
condition (Figure 1).
Acute encephalitis with refractory, repetitive partial
seizures (AERRPS) is defined by five criteria: (1) A prolonged
acute phase of more than 2 weeks; (2) partial seizures with
the same symptoms persisting from the acute phase until
the convalescent phase; (3) seizures frequently evolving to
status epilepticus, especially during the acute phase; (4)
marked intractability of seizures; and (5) exclusion of
related disorders such as known viral encephalitis or
metabolic disorders.13,15,17 The clinical entity of AERRPS
arose in 1986, when Awaya et al described five cases of
peculiar onset postencephalitic epilepsy in Japan.18 He
found a novel subtype of epilepsy characterized bycephalitis to the convalescent phase. In 2001, Sakuma et al
proposed the term AERRPS to integrate the characteristics
of these entities.19 From different clinical presentations
with a focus on brain images, a further two cases were
reported in Japan as acute infantile encephalopathy pre-
dominantly affecting the frontal lobes (AIEF) and acute
encephalopathy with biphasic seizures and late reduced
diffusion (AESD).20,21
Febrile infection-related epilepsy syndrome (FIRES) was
first described by vanBaalen et al in 2010 with the following
inclusion criteria: previously healthy children with recur-
rent seizures or status epilepticus (30 minutes or more) 2-28
days after onset of an acute, banal febrile illness and
lacking evidence of infectious agents in CSF. Exclusion
criteria were febrile seizures and seizures triggered by
fever in children with epilepsy.22 Typically, banal febrile
infection of different origins is followed by a similar clinical
course, and it is characterized by an acute onset of re-
fractory seizures. In fact, in 2009, another abbreviation
FIRES was initially mentioned by van Baalen et al, which
was defined as “fever-induced refractory epileptic en-
cephalopathy in school-aged children”.23 This condition
was first called ‘‘devastating epileptic encephalopathy in
school age children’’ (DESC).24 A similar condition to FIRES
has been reported in young adults and was referred to as
new-onset refractory status epilepticus (NORSE).25 Seven
women aged 20-52 years (mean 33 years) presented after a
febrile illness of unknown etiology with severe long-lasting
status epilepticus with neurological deterioration. All of
these different medical terms emphasized preceding banal
febrile infection followed by refractory seizures (status
epilepticus) in different age groups and when pathogen
detection in CSF failed.
Acute encephalopathy with inflammation-mediated
status epilepticus (AEIMSE) was introduced by Nabbout
et al in 2011.13 They focused on the pathogenesis of
possible inflammation-induced status epilepticus. It seems
that pediatric inflammation-mediated encephalopathies
with status epilepticus are distinct from encephalitis. They
probably result from the combination effects of inflamma-
tion and major seizure activity.13e17 The seizure activity
itself results partly from inflammation and contributes to
inflammation, generating a vicious cycle that leads to sta-
tus epilepticus.13 Nabbout et al suggest that AEIMSE in-
cludes three different entities according to the age. The
three conditions include: (1) Idiopathic hemi-
convulsionehemiplegia syndrome (IHHS) in infancy that
mostly occurs in the age group of 1-4 years; (2) FIRES is
reported in children between 4 years of age and adoles-
cence; and (3) NORSE occurs in adulthood.13,22,23,25,26
AEIMSE is focussed on the inflammation process for the
possible mechanism of these clinical conditions.133. The role of antineuronal antibodies in
encephalopathy and febrile status epilepticus
Over the past few decades, the number of antineuronal
antibodies to ion channels, receptors, and other synaptic
proteins described in association with central nervous sys-
tem disorders has increased dramatically, especially
Febrile status epilepticus
Yes
Encephalopathy Febrile seizure with status epilepticus
No
Evidence of infectious pathogen in CSF Confirmed encephalitis with 
status epilepticus
Yes
No
Presumed encephalitis with status epilepticus
Evidence of infectious pathogens other than CSF (antibodies in serum; virus in throat/rectum)
No
Different clinical focus 
Antecedent febrile 
infection + encephalopathy
+ inflammation process + 
status epilepticus
Antecedent febrile infection
+ encephalopathy + 
refractory seizures
Antecedent febrile infection
+ encephalopathy + 
refractory partial seizures
AEIMSEFIRESAERRPS
Spectrum of encephalitis/encephalopathy with febrile status epilepticus
Yes
Figure 1 Flow chart of clinical considerations from the presentation of febrile status epilepticus to the spectrum of related
conditions of children with encephalitis/encephalopathy and febrile status epilepticus. The abbreviated medical terms used in
different areas and study groups describes these similar conditions in literature, all of which represent the unique characteristics as
a part of this condition. AIEMSE Z acute encephalopathy with inflammation-mediated status epilepticus; AERRPS Z acute en-
cephalitis with refractory, repetitive partial seizures; CSF Z cerebrospinal fluid; FIRES Z febrile infection-related epilepsy
syndrome.
Antineuronal antibodies and febrile status epilepticus 163considering their roles in pediatric encephalitis and status
epilepticus.9,10,27e29 These antineuronal antibodies are
divided according to the location of their respective anti-
gens: (1) Intracellular antigens, including glutamic acid
decarboxylase (GAD), and classical onconeural antigens
such as Hu (antineuronal nuclear antibody 1, ANNA1), Ma2,
Yo (Purkinje cell autoantibody, PCA1), Ri (antineuronal
nuclear antibody 2, ANNA2), CV2/CRMP5 (collapsin
response mediator protein 5 antibody), and amphiphysin;and (2) cell membrane ion channels or surface antigens
including voltage-gated potassium channel receptor
(VGKC), N-methyl-D-aspartate receptor (NMDA), a-amino-3-
hydroxy-5-methyl-4-isoxazole propionic acid receptor
(AMPA), g-aminobutyric acid(B) receptor (GABA), leucine-
rich glioma-inactivated protein 1 (LGI1) and contactin-
associated protein-like 2 (CASPR2) (Table 1).9,10,30
Autoantibodies to surface proteins that influence
neuronal excitability are increasingly found in different
Table 1 Antineuronal autoantibodies to intracellular antigens and cell-surface antigens.
Intracellular antigens Cell-surface antigens
Onconeuronal antigens GAD Glutamate receptors GABAB receptors VGKC-zassociated proteins
Amphiphysin MA2 Ri Yo Hu NMDA AMPA1 AMPA2 CASPR2 LGI1
AMPA Z a-amino-3-hydroxy-5-methyl-4- isoxazole propionic acid; CASPR2 Z contactin-associated protein-like 2; GABA Z g-amino-
butyric acid; GAD Z glutamic acid decarboxylase; LGI1 Z leucine-rich, gliomaeinactivated protein 1; NMDA Z N-Methyl-D-aspartate;
VGKC Z voltage-gated potassium channel.
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are beginning to be identified in children. All of the above
antibodies, except antibodies to GAD and classical onco-
neural antigens, are directed against the extracellular do-
mains of membrane proteins and are highly likely to be
pathogenic for seizure and status epilepticus.30,31 Never-
theless, intracellular antineuronal autoantibodies (anti-
bodies to GAD and classical onconeural antigens) are also
found to play a role in children with encephalopathy and
febrile status epilepticus and related conditions.32e34
3.1. Anti-GAD antibody-related encephalopathy
and febrile status epilepticus
High-titer GAD antibodies usually associate with non-
paraneoplastic stiff-person syndrome and cerebellar
dysfunction; however an increasing number of reports show
that these antibodies also associate with subtypes of limbic
encephalitis and refractory epilepsy.35 GAD is the rate-
limiting enzyme for the synthesis of GABA, the major
inhibitory neurotransmitter in the central nervous system.
The mechanism underlying seizures in anti-GAD antibody-
related epilepsy likely involves the downregulation of
cortical GABAergic neurotransmission.36 The presence of
anti-GAD antibodies suggests that the underlying neurologic
syndrome may be immune mediated.37 Lin et al examined
antibodies to GAD and cell membrane ion channels or sur-
face antigens in acute-phase serum from 17 children with
encephalitis and status epilepticus.32 Anti-GAD antibody
titers were compared with those of control children mani-
festing therapy-resistant epilepsy. Anti-GAD antibody titers
were significantly higher in children with encephalitis and
status epilepticus than in those with therapy-resistant ep-
ilepsy. Six children exhibited positive anti-GAD antibodies.
Three manifested postencephalitic epilepsy with neuro-
logic deficits. Higher anti-GAD antibody titers were evident
in children with encephalitis and status epilepticus.
Although the study produced no direct evidence for the
pathogenesis of anti-GAD antibodies, the potential role of
anti-GAD antibodies in children with encephalitis and status
epilepticus should be emphasized.
3.2. Anti-NMDA receptor antibody-related
encephalopathy and febrile status epilepticus
The anti-NMDA receptor antibody-related encephalopathy
was first reported in association with ovarian teratomas. It
was mainly reported in teenage or young adult women, and
very occasionally with other tumors.38,39 However, it is now
clear that there are many patients, particularly younger
children and both sexes older than 40 years of age, whohave the nonparaneoplastic form.40,41 Dalmau et al re-
ported on a series of 100 patients with anti-NMDA-receptor
encephalitis, and observed a female (91%) predominance,
with a median age of 23 years (range: 5-76 years). All pa-
tients presented with psychiatric signs or memory prob-
lems, and 86% exhibited a nonspecific viral-like illness with
low-grade fever within 2 weeks before hospital admission.38
Seizures were evident in 76% of the patients with anti-
NMDA-receptor encephalitis in the study by Dalmau et al,
without the mention of the percentage of status epi-
lepticus.38 However, nonconvulsive status epilepticus has
also been reported.42e44 Antibody against glutamate re-
ceptor epsilon-2 subunit, also designated as NMDA re-
ceptors 2B subunit, is positive in serum or CSF in more than
a half of the AERRPS patients. This antibody is usually
detected within 2 weeks from onset.17 In the clinical course
of anti-NMDA-receptor antibodies encephalitis, seizures
and status epilepticus can resurface at any time during the
illness.39
3.3. VGKC complex antibody-related
encephalopathy and febrile status epilepticus
VGKC complex antibodies are reported in a range of central
and peripheral neurologic disorders in adults. Recently,
they have also been increasingly recognized in children,
including limbic encephalitis, FIRES, early-onset epileptic
encephalopathy, and unexplained encephalitis presenting
with status epilepticus.28,34,45,46 Originally, the antibodies
were thought to be directed against the VGKC themselves.
However, these antibodies were subsequently found to bind
to proteins that are part of a VGKC complex, including LGI1
and CASPR2. Thus, they are better termed as VGKC com-
plex antibodies.47,48 In VGKC complex antibody-associated
limbic encephalitis in adults, patients typically present
with acute to subacute onset memory loss, confusion,
medial temporal lobe seizures, agitation, and psychiatric
features evolving over several days or weeks.9,10,30 Most
patients are older than 40 years, with a male predominance
(2:1 ratio).47 However, different clinical features of VGKC
complex antibody-associated encephalitis have been re-
ported recently in children.28,34,46 These were character-
ized by normal neurodevelopmental status before the onset
of febrile illness, seizure at presentation, sometimes asso-
ciated with status epilepticus, features of encephalopathy
(e.g., behavior disturbance, confusion, disorientation, and
hallucinations) and cognitive decline, without identifiable
infectious etiology. Reviewing previous related literature,
11 patients (8 girls and 3 boys, aged 1-16 years) were re-
ported with VGKC complex antibody-related encephalopa-
thy. The major neurologic symptoms were seizure (n Z 8,
72.3%) including status epilepticus (nZ 5, 45.5%).28,34,46,49
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encephalomyelitis from spectrum of
encephalopathy and febrile status epilepticus
From an immunological aspect, acute disseminated
encephalomyelitis and a spectrum of encephalopathy and
febrile status epilepticus are possible immune-mediated
central nervous system diseases. Antineuronal antibodies
are found to be the pathogenic mechanism of these dis-
eases. Nevertheless, acute disseminated encephalomy-
elitis has a more favorable outcome, and fewer seizure
occurrences. It is a monophasic inflammatory demyelin-
ating condition of the central nervous system. It typically
occurs following a viral prodrome or vaccination and usu-
ally presents with multifocal neurological disturbance
accompanied by changes in mental status.50 Brain mag-
netic resonance imaging is regarded as the diagnostic
imaging modality of choice and usually demonstrates
white matter lesions, although the involvement of gray
matter is not uncommon.51 Antimyelin oligodendrocyte
glycoprotein antibodies are transient and continuously
declined in the patients with acute disseminated
encephalomyelitis.525. Management of antineuronal antibodies-
related encephalopathy and febrile status
epilepticus in children
With regard to management, autoimmune encephalitis may
be treatable with immunotherapy.9,10,28,30 Prompt diag-
nosis and treatment with immunosuppressants can improve
or even reverse symptoms. Pediatric patients with en-
cephalitis and febrile status epilepticus have common
symptoms and signs of acute encephalitis and status epi-
lepticus. However, it was still difficult to differentiate be-
tween viral and immune-mediated encephalitis by clinical
manifestations. Thus, aside from empirical anti-infectious
treatment and antiepileptic drugs, immune-modulating
therapies were considered. Regardless of whether the in-
fectious pathogens were found, other than in CSF, identi-
fying an antineuronal autoantibody may be a reference for
the option of immunotherapy treatment. In some anti-
neuronal antibody-confirmed cases, if left untreated,
retrospective case series have shown that these conditions
can lead to irreversible cognitive deficits, ongoing seizures,
and even death. Although the evidence is limited to
retrospective series and case reports, the best available
data suggest that early treatment with intravenous immu-
noglobulin or plasmapheresis (or both) followed by long-
term immunosuppression (typically with corticosteroids) is
associated with improved outcomes.9,10 Other treatments,
including cyclophosphamide and rituximab, have been
successful in individual patients.9,10,53 Seizures are often
refractory to standard treatments, but may remit with
immunotherapy. In the study of Lin et al, there was no
evidence of the positive effects of immunotherapy in the
anti-GAD-positive children compared with the anti-GAD-
negative group.32 Future studies should include a greater
number of cases and accumulate the experience of inter-
national studies.Nakagawa et al reported 12 children with febrile re-
fractory status epilepticus who underwent therapeutic hy-
pothermia (34 C) with general anesthesia, and they
concluded that therapeutic hypothermia significantly
improved the outcomes compared to conventional ther-
apy.54 Lin’s group presented two pediatric cases of FIRES
who were refractory to conventional medical therapy.
Moderate therapeutic hypothermia of 33 C resulted in fast
and sustained control of refractory status epilepticus. After
3 months, both patients recovered with a Glasgow Outcome
Scale of 4.55 Furthermore, a ketogenic diet was reported to
be an alternative efficacious therapy for FIRES by Nabbout
et al.56 Thus, both therapeutic hypothermia and a keto-
genic diet are alternative therapies that can be applied in
these similar clinical conditions of children with encepha-
litis and febrile status epilepticus.
6. Conclusion
From the clinical observation of children with status epi-
lepticus, presumed central nervous system infection appears
to be marker for morbidity and mortality. An Immunological
mechanismmight act as a trigger between presumed central
nervous system infection and febrile status epilepticus.
Antineuronal autoantibodies were found to play an impor-
tant role in these patients in recent decades. Therefore,
clinicians need to be able to recognize these clinical pre-
sentations because early diagnosis and optimal treatment
may improve the outcome. Nevertheless, future studies with
more experience accumulation are warranted.
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